Melanocortin 4 Receptor Agonist [EPC]

Melanocortin 4 Receptor Agonist [EPC] was reported 285 times

Drugs of the Melanocortin 4 Receptor Agonist [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 REACTIVE ANGIOENDOTHELIOMATOSIS 1 0.3333
1 HYPOTHALAMIC OBESITY 1 0.2500
2 LEPTIN LEVEL INCREASED 1 0.0909
3 OROPHARYNGEAL COBBLE STONE MUCOSA 1 0.0714
4 GASPING SYNDROME 1 0.0476
5 MALE GENITAL EXAMINATION ABNORMAL 1 0.0435
6 MELANODERMA 7 0.0365
7 ENDOMETRIAL HYPERPLASIA WITH CELLULAR ATYPIA 1 0.0357
8 SUPERFICIAL SPREADING MELANOMA STAGE I 1 0.0278
9 THYROID NODULE REMOVAL 1 0.0250
10 OLFACTORY DYSFUNCTION 1 0.0238
11 IRIS DISCOLOURATION 1 0.0217
12 SPONTANEOUS PENILE ERECTION 13 0.0209
13 EPHELIDES 11 0.0204
14 OPTIC DISC DRUSEN 1 0.0159
15 EXERTIONAL HEADACHE 1 0.0156
16 POLYMERS ALLERGY 1 0.0145
17 CSF SHUNT OPERATION 1 0.0139
18 DYSPLASTIC NAEVUS 5 0.0139
19 RAOULTELLA ORNITHINOLYTICA INFECTION 1 0.0130
20 DYSANIA 1 0.0130
21 PIGMENTATION LIP 1 0.0093
22 OPTIC DISC OEDEMA 1 0.0086
23 MENSTRUAL DISCOMFORT 1 0.0083
24 SKIN HYPERPIGMENTATION 64 0.0074
25 CIRCUMCISION 1 0.0071
26 TANNING 1 0.0068
27 DIAPHRAGMATIC SPASM 1 0.0068
28 FEAR-RELATED AVOIDANCE OF ACTIVITIES 1 0.0066
29 FALLOPIAN TUBE CYST 1 0.0062
30 UROBILINOGEN URINE INCREASED 1 0.0061
31 MELANOCYTIC NAEVUS 25 0.0057
32 BLOOD TEST 1 0.0053
33 BLOOD KETONE BODY PRESENT 1 0.0053
34 HERNIA HIATUS REPAIR 1 0.0049
35 INJECTION SITE PLAQUE 1 0.0048
36 COLD URTICARIA 1 0.0045
37 PAINFUL ERECTION 3 0.0044
38 OLIGODIPSIA 1 0.0043
39 BIOPSY SKIN ABNORMAL 1 0.0042
40 NAIL PIGMENTATION 1 0.0041
41 KERATOSIS PILARIS 1 0.0040
42 DELAYED PUBERTY 1 0.0039
43 DUMPING SYNDROME 1 0.0038
44 OESOPHAGEAL FOOD IMPACTION 2 0.0036
45 PRECOCIOUS PUBERTY 2 0.0035
46 GENERALISED PUSTULAR PSORIASIS 1 0.0034
47 ADRENOCORTICOTROPIC HORMONE DEFICIENCY 3 0.0034
48 LIP DISCOLOURATION 4 0.0032
49 ADNEXAL TORSION 1 0.0032
50 WEIGHT LOSS POOR 16 0.0031
51 DRUG TITRATION ERROR 8 0.0031
52 INJECTION SITE HYPERTROPHY 1 0.0031
53 CENTRAL HYPOTHYROIDISM 1 0.0030
54 BENIGN NEOPLASM OF SKIN 1 0.0030
55 DIAPHRAGMALGIA 1 0.0029
56 FIBROUS HISTIOCYTOMA 1 0.0028
57 MUSCLE HYPERTROPHY 1 0.0028
58 EAR OPERATION 1 0.0027
59 INTRACRANIAL TUMOUR HAEMORRHAGE 1 0.0026
60 FAT TISSUE DECREASED 1 0.0026
61 BONE DENSITY INCREASED 1 0.0025
62 SARCOPENIA 1 0.0023
63 HAEMANGIOMA OF SKIN 1 0.0023
64 REFUSAL OF TREATMENT BY RELATIVE 1 0.0022
65 HERNIA PAIN 1 0.0022
66 DIABETES INSIPIDUS 5 0.0021
67 BODY HEIGHT INCREASED 1 0.0020
68 HEART FAILURE WITH REDUCED EJECTION FRACTION 1 0.0019
69 INTERTRIGO 1 0.0018
70 BURNOUT SYNDROME 1 0.0018
71 ENDOMETRIAL ADENOCARCINOMA 1 0.0016
72 THYROXINE FREE INCREASED 1 0.0016
73 WRONG DEVICE USED 1 0.0015
74 ARTHROSCOPY 1 0.0015
75 OPHTHALMIC MIGRAINE 1 0.0014
76 FLUID IMBALANCE 1 0.0014
77 FACIAL DISCOMFORT 1 0.0014
78 OVARIAN MASS 1 0.0014
79 PHIMOSIS 1 0.0014
80 PRECANCEROUS SKIN LESION 2 0.0014
81 APRAXIA 2 0.0013
82 SOFT TISSUE INJURY 1 0.0013
83 SENSITISATION 1 0.0013
84 TRACHEITIS 1 0.0013
85 PRODUCT INEFFECTIVE 1 0.0013
86 RETINAL PIGMENTATION 1 0.0013
87 CROUP INFECTIOUS 1 0.0013
88 VITAMIN B12 INCREASED 1 0.0013
89 SKIN BACTERIAL INFECTION 1 0.0012
90 HUNGER 17 0.0012
91 HAND-FOOT-AND-MOUTH DISEASE 1 0.0012
92 TONSILLECTOMY 2 0.0012
93 SUPERFICIAL VEIN THROMBOSIS 1 0.0012
94 AMAUROSIS 1 0.0012
95 INJECTION SITE NODULE 13 0.0012
96 SOLILOQUY 1 0.0012
97 JAW OPERATION 1 0.0011
98 HYPOGLYCAEMIC SEIZURE 1 0.0011
99 FIBROMA 1 0.0011
100 DISTURBANCE IN SEXUAL AROUSAL 1 0.0011
101 SOLAR LENTIGO 1 0.0011
102 ADRENOCORTICAL INSUFFICIENCY ACUTE 2 0.0010
103 HYPERPHAGIA 4 0.0010
104 DROWNING 1 0.0010
105 ERECTION INCREASED 4 0.0010
106 HALLUCINATIONS, MIXED 4 0.0010
107 FOOD CRAVING 5 0.0009
108 BINGE EATING 1 0.0009
109 AORTIC DILATATION 1 0.0009
110 INCREASED APPETITE 17 0.0009
111 IDIOPATHIC INTRACRANIAL HYPERTENSION 2 0.0009
112 PRIAPISM 3 0.0009
113 DEVICE DISPENSING ERROR 1 0.0008
114 STAPHYLOCOCCAL SKIN INFECTION 1 0.0008
115 PIGMENTATION DISORDER 5 0.0008
116 BLOOD ELECTROLYTES ABNORMAL 1 0.0008
117 INTERVERTEBRAL DISC OPERATION 1 0.0008
118 RENAL ATROPHY 1 0.0008
119 BILIARY OBSTRUCTION 1 0.0008
120 FEELINGS OF WORTHLESSNESS 1 0.0008
121 SKIN DISCOLOURATION 35 0.0008
122 FEELING GUILTY 1 0.0008
123 CULTURE URINE POSITIVE 1 0.0007
124 INJECTION SITE HYPOAESTHESIA 1 0.0007
125 NOROVIRUS INFECTION 1 0.0007
126 TONGUE DISCOLOURATION 3 0.0007
127 SLEEP PARALYSIS 1 0.0007
128 GROWTH RETARDATION 2 0.0007
129 AXILLARY PAIN 1 0.0007
130 IMPETIGO 1 0.0007
131 SUPERINFECTION 1 0.0007
132 INFECTIOUS PLEURAL EFFUSION 1 0.0007
133 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 1 0.0007
134 VIOLENCE-RELATED SYMPTOM 1 0.0006
135 NEOPLASM SKIN 1 0.0006
136 SUBSTANCE USE 1 0.0006
137 GLYCOSYLATED HAEMOGLOBIN DECREASED 1 0.0006
138 SHOULDER FRACTURE 1 0.0006
139 PRODUCT PREPARATION ISSUE 4 0.0006
140 MEDICAL PROCEDURE 1 0.0006
141 FLUID INTAKE REDUCED 3 0.0006
142 EROSIVE OESOPHAGITIS 1 0.0006
143 SEIZURE LIKE PHENOMENA 1 0.0006
144 HYPOPITUITARISM 1 0.0006
145 INTRA-ABDOMINAL FLUID COLLECTION 1 0.0006
146 HYPERSEXUALITY 1 0.0005
147 SINUS NODE DYSFUNCTION 1 0.0005
148 SUSPECTED PRODUCT QUALITY ISSUE 1 0.0005
149 BLOOD CHOLESTEROL DECREASED 1 0.0005
150 NARCOLEPSY 1 0.0005
151 INTENTIONAL DOSE OMISSION 15 0.0005
152 MENOMETRORRHAGIA 1 0.0005
153 THYROID MASS 2 0.0005
154 SOCIAL AVOIDANT BEHAVIOUR 3 0.0005
155 RHEUMATIC DISORDER 1 0.0005
156 CONVERSION DISORDER 1 0.0005
157 EARLY SATIETY 1 0.0005
158 PRODUCT DOSE OMISSION IN ERROR 14 0.0005
159 DEREALISATION 1 0.0005
160 GASTRIC BYPASS 1 0.0005
161 ABNORMAL LOSS OF WEIGHT 3 0.0004
162 DISCOURAGEMENT 1 0.0004
163 ORAL SURGERY 1 0.0004
164 SUBCUTANEOUS ABSCESS 2 0.0004
165 INTRAVENTRICULAR HAEMORRHAGE 1 0.0004
166 HYPERNATRAEMIA 2 0.0004
167 INJECTION SITE IRRITATION 5 0.0004
168 INJECTION SITE INDURATION 5 0.0004
169 TONSILLITIS 2 0.0004
170 PERSONALITY DISORDER 1 0.0004
171 ORAL FUNGAL INFECTION 1 0.0004
172 HYPOMENORRHOEA 1 0.0004
173 INTRACRANIAL PRESSURE INCREASED 2 0.0004
174 HYPOPHAGIA 9 0.0004
175 INJECTION SITE SCAR 1 0.0004
176 VOMITING PROJECTILE 1 0.0003
177 INJECTION SITE PRURITUS 23 0.0003
178 CEREBROVASCULAR DISORDER 1 0.0003
179 ADRENAL INSUFFICIENCY 4 0.0003
180 SCOLIOSIS 2 0.0003
181 AFFECT LABILITY 3 0.0003
182 REFUSAL OF TREATMENT BY PATIENT 2 0.0003
183 ANXIETY DISORDER 1 0.0003
184 WOUND DEHISCENCE 1 0.0003
185 INITIAL INSOMNIA 3 0.0003
186 REGURGITATION 1 0.0003
187 CERVICAL VERTEBRAL FRACTURE 1 0.0003
188 FOOD INTOLERANCE 1 0.0003
189 THERAPEUTIC PRODUCT EFFECT VARIABLE 1 0.0003
190 RHINOVIRUS INFECTION 1 0.0003
191 MUSCLE RUPTURE 1 0.0003
192 NAIL DISCOLOURATION 1 0.0003
193 RENAL CYST 2 0.0003
194 ENURESIS 1 0.0002
195 INJECTION SITE URTICARIA 6 0.0002
196 ANAPHYLACTOID REACTION 1 0.0002
197 SOCIAL PROBLEM 1 0.0002
198 THYROID FUNCTION TEST ABNORMAL 1 0.0002
199 SELF-INJURIOUS IDEATION 1 0.0002
200 INJECTION SITE BRUISING 19 0.0002
201 ATTENTION DEFICIT HYPERACTIVITY DISORDER 1 0.0002
202 MUSCLE FATIGUE 1 0.0002
203 TEARFULNESS 1 0.0002
204 ANURIA 2 0.0002
205 CHAPPED LIPS 1 0.0002
206 ONYCHOMYCOSIS 1 0.0002
207 THERAPY INTERRUPTED 16 0.0002
208 AGGRESSION 11 0.0002
209 BLOOD PRESSURE DIASTOLIC INCREASED 1 0.0002
210 LOCALISED OEDEMA 1 0.0002
211 HYPOVOLAEMIC SHOCK 1 0.0002
212 PARAESTHESIA ORAL 3 0.0002
213 ANGER 7 0.0002
214 PHARYNGEAL SWELLING 2 0.0002
215 INJECTION SITE INFLAMMATION 1 0.0002
216 PROTEIN URINE PRESENT 1 0.0002
217 ERYSIPELAS 1 0.0002
218 WEIGHT FLUCTUATION 2 0.0002
219 PARTIAL SEIZURES 1 0.0002
220 CYANOSIS 3 0.0002
221 INJECTION SITE DISCOMFORT 2 0.0002
222 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
223 FOOD POISONING 1 0.0002
224 DECREASED ACTIVITY 2 0.0002
225 HIP SURGERY 1 0.0002
226 HYDROCEPHALUS 1 0.0002
227 MOOD ALTERED 5 0.0002
228 FAECALOMA 1 0.0002
229 HYPERKERATOSIS 1 0.0002
230 OBSTRUCTIVE AIRWAYS DISORDER 2 0.0002
231 INTERMENSTRUAL BLEEDING 1 0.0002
232 MALNUTRITION 2 0.0002
233 INJECTION SITE ERYTHEMA 22 0.0002
234 STATUS EPILEPTICUS 2 0.0002
235 HYPERVENTILATION 1 0.0002
236 HYPOVOLAEMIA 1 0.0002
237 HYPERTRIGLYCERIDAEMIA 1 0.0002
238 THIRST 3 0.0002
239 TYPE 1 DIABETES MELLITUS 1 0.0002
240 ILLNESS 17 0.0002
241 TENSION 1 0.0002
242 INJECTION SITE MASS 6 0.0002
243 HAIR COLOUR CHANGES 2 0.0002
244 INJECTION SITE DISCOLOURATION 2 0.0002
245 INCOHERENT 1 0.0002
246 DEPRESSED MOOD 8 0.0002
247 APPETITE DISORDER 1 0.0002
248 SKIN MASS 1 0.0001
249 HAIR TEXTURE ABNORMAL 2 0.0001
250 BREAST MASS 1 0.0001
251 INTENTIONAL SELF-INJURY 3 0.0001
252 POSTOPERATIVE WOUND INFECTION 1 0.0001
253 SINUS CONGESTION 2 0.0001
254 GENERAL PHYSICAL CONDITION ABNORMAL 1 0.0001
255 BLOOD TESTOSTERONE DECREASED 1 0.0001
256 DROOLING 1 0.0001
257 LYMPHOEDEMA 1 0.0001
258 HAIR GROWTH ABNORMAL 1 0.0001
259 AUTOIMMUNE HEPATITIS 1 0.0001
260 INJECTION SITE SWELLING 11 0.0001
261 DEFAECATION URGENCY 1 0.0001
262 FEAR OF INJECTION 1 0.0001
263 BRONCHOSPASM 2 0.0001
264 MENTAL DISORDER 6 0.0001
265 FAECES SOFT 1 0.0001
266 APATHY 2 0.0001
267 INTENTIONAL UNDERDOSE 1 0.0001
268 MAJOR DEPRESSION 1 0.0001
269 PAROSMIA 1 0.0001
270 LIPASE INCREASED 1 0.0001
271 ANKLE FRACTURE 2 0.0001
272 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
273 OCULAR HYPERAEMIA 6 0.0001
274 HALLUCINATION, AUDITORY 2 0.0001
275 RHINITIS 1 0.0001
276 FRUSTRATION TOLERANCE DECREASED 1 0.0001
277 HYPOGLYCAEMIA 6 0.0001
278 MUSCLE DISORDER 1 0.0001
279 BLOOD POTASSIUM INCREASED 2 0.0001
280 POST PROCEDURAL INFECTION 1 0.0001
281 POLYURIA 1 0.0001
282 MENSTRUAL DISORDER 1 0.0001
283 FACIAL PARALYSIS 1 0.0001
284 DECREASED APPETITE 27 0.0001
285 BLOOD MAGNESIUM DECREASED 1 0.0001
286 URINE OUTPUT DECREASED 1 0.0001
287 HYPOXIA 4 0.0001
288 EAR INFECTION 3 0.0001
289 WEIGHT INCREASED 25 0.0001
290 THERAPEUTIC RESPONSE UNEXPECTED 5 0.0001
291 HEAVY MENSTRUAL BLEEDING 1 0.0001
292 THROAT TIGHTNESS 3 0.0001
293 GASTROENTERITIS VIRAL 2 0.0001
294 LIP DRY 1 0.0001
295 CRYING 4 0.0001
296 HEPATIC STEATOSIS 2 0.0001
297 MIDDLE INSOMNIA 2 0.0001
298 APPENDICITIS 1 0.0001
299 DIARRHOEA HAEMORRHAGIC 1 0.0001
300 FLANK PAIN 1 0.0001
301 HYPONATRAEMIA 6 0.0001
302 PHOTOPHOBIA 2 0.0001
303 BLOOD SODIUM DECREASED 2 0.0001
304 SPINAL DISORDER 1 0.0001
305 HERNIA 2 0.0001
306 DIZZINESS POSTURAL 1 0.0001
307 NAUSEA 81 0.0001
308 INJECTION SITE REACTION 7 0.0001
309 KNEE OPERATION 1 0.0001
310 ABNORMAL BEHAVIOUR 4 0.0001
311 BLOOD POTASSIUM DECREASED 3 0.0001
312 ABDOMINAL PAIN 23 0.0001
313 HYPOTHERMIA 1 0.0001
314 DRY THROAT 1 0.0001
315 SUICIDAL IDEATION 9 0.0001
316 INJECTION SITE RASH 3 0.0001
317 HOSPITALISATION 15 0.0001
318 INJECTION SITE WARMTH 2 0.0001
319 INCONTINENCE 1 0.0001
320 MOOD SWINGS 3 0.0001
321 EATING DISORDER 2 0.0001
322 RETCHING 2 0.0001
323 BREAST PAIN 1 0.0001
324 JOINT INJURY 2 0.0001
325 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
326 BIPOLAR DISORDER 1 0.0001
327 BACK INJURY 1 0.0001
328 CHOLELITHIASIS 3 0.0001
329 VOMITING 43 0.0001
330 OFF LABEL USE 79 0.0001
331 URINARY RETENTION 3 0.0001
332 SNEEZING 2 0.0001
333 SKIN INFECTION 1 0.0001
334 INTESTINAL PERFORATION 1 0.0001
335 CHROMATURIA 2 0.0001
336 POST PROCEDURAL HAEMORRHAGE 1 0.0001
337 SPINAL PAIN 1 0.0001
338 SURGERY 5 0.0001
339 BACTERAEMIA 1 0.0001
340 CHOLECYSTITIS 1 0.0001
341 MYOCLONUS 1 0.0001
342 ACCIDENT 1 0.0001
343 ABDOMINAL DISCOMFORT 14 0.0001
344 ABDOMINAL PAIN UPPER 17 0.0001
345 AGITATION 6 0.0001
346 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
347 SMALL INTESTINAL OBSTRUCTION 1 0.0001
348 TENDON RUPTURE 1 0.0001
349 HYPERCALCAEMIA 1 0.0001
350 PHARYNGITIS 1 0.0001
351 GLYCOSYLATED HAEMOGLOBIN INCREASED 2 0.0001
352 FLUID RETENTION 4 0.0001
353 INTRAOCULAR PRESSURE INCREASED 1 0.0001
354 GASTROINTESTINAL DISORDER 7 0.0001
355 NODULE 1 0.0001
356 SARS-COV-2 TEST POSITIVE 1 0.0001
357 ADVERSE REACTION 1 0.0001
358 PALLOR 2 0.0001
359 IMPAIRED GASTRIC EMPTYING 1 0.0001
360 TREATMENT NONCOMPLIANCE 4 0.0001
361 SKIN LESION 2 0.0001
362 FEELING COLD 2 0.0001
363 HYPOMAGNESAEMIA 1 0.0001
364 INJECTION SITE PAIN 22 0.0001
365 APHONIA 1 0.0001
366 SKIN REACTION 1 0.0001
367 SLEEP DISORDER 5 0.0001
368 SEASONAL ALLERGY 1 0.0001
369 PARALYSIS 1 0.0001
370 ACCIDENTAL UNDERDOSE 1 0.0001
371 SEIZURE 8 0.0001
372 GASTROENTERITIS 1 0.0001
373 PRODUCT DOSE OMISSION ISSUE 20 0.0001
374 COLITIS ULCERATIVE 3 0.0001
375 HEADACHE 42 0.0001
376 IRRITABILITY 4 0.0001
377 HYPOAESTHESIA ORAL 1 0.0001
378 DISCOMFORT 4 0.0001
379 EPILEPSY 2 0.0001
380 FEELING HOT 4 0.0001
381 DEVICE RELATED INFECTION 1 0.0001
382 THYROID DISORDER 1 0.0001
383 EMOTIONAL DISORDER 2 0.0001
384 LIMB DISCOMFORT 2 0.0001
385 SOMNOLENCE 13 0.0001
386 DELUSION 1 0.0001
387 CONSTIPATION 14 0.0001
388 BASAL CELL CARCINOMA 1 0.0001
389 HEAD INJURY 2 0.0001
390 DRUG INTOLERANCE 6 0.0001
391 MANIA 1 0.0001
392 VISUAL ACUITY REDUCED 2 0.0001
393 SYNCOPE 6 0.0001
394 NASOPHARYNGITIS 11 0.0001
395 PERICARDITIS 1 0.0001
396 HYPERSENSITIVITY 11 0.0001
397 HEMIPARESIS 1 0.0001
398 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1 0.0001
399 DIARRHOEA 38 0.0001
400 SCAR 1 0.0001
401 PARANOIA 1 0.0001
402 ECZEMA 3 0.0001
403 SYRINGE ISSUE 1 0.0001
404 COLD SWEAT 1 0.0001
405 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
406 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
407 HEAD DISCOMFORT 1 0.0001
408 ASPARTATE AMINOTRANSFERASE INCREASED 3 0.0001
409 GALLBLADDER DISORDER 1 0.0001
410 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 10 0.0001
411 RESTLESS LEGS SYNDROME 1 0.0001
412 PANIC ATTACK 2 0.0001
413 END STAGE RENAL DISEASE 1 0.0001
414 ACCIDENTAL OVERDOSE 2 0.0001
415 RESTLESSNESS 2 0.0001
416 BLOOD GLUCOSE ABNORMAL 1 0.0001
417 THINKING ABNORMAL 1 0.0001
418 HEPATIC CIRRHOSIS 1 0.0001
419 FLATULENCE 3 0.0001
420 HYPOCALCAEMIA 1 0.0001
421 FRACTURE 1 0.0001
422 SLEEP APNOEA SYNDROME 1 0.0001
423 CHOLESTASIS 1 0.0001
424 ERUCTATION 1 0.0001
425 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
426 SINUS DISORDER 1 0.0001
427 FEEDING DISORDER 1 0.0000
428 TASTE DISORDER 1 0.0000
429 FLUSHING 5 0.0000
430 INJURY ASSOCIATED WITH DEVICE 1 0.0000
431 MUSCLE SPASMS 9 0.0000
432 ALANINE AMINOTRANSFERASE INCREASED 3 0.0000
433 RIB FRACTURE 1 0.0000
434 DEPRESSION 11 0.0000
435 ASTHENIA 18 0.0000
436 RENAL IMPAIRMENT 4 0.0000
437 IMPAIRED WORK ABILITY 1 0.0000
438 SKIN CANCER 1 0.0000
439 RHINORRHOEA 3 0.0000
440 FATIGUE 36 0.0000
441 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
442 TACHYCARDIA 4 0.0000
443 INFLUENZA 5 0.0000
444 THERAPEUTIC PRODUCT EFFECT DECREASED 2 0.0000
445 THERAPY NON-RESPONDER 2 0.0000
446 PRODUCT AVAILABILITY ISSUE 1 0.0000
447 NEPHROLITHIASIS 2 0.0000
448 TINNITUS 2 0.0000
449 HYPOKALAEMIA 2 0.0000
450 CHILLS 5 0.0000
451 DYSPHAGIA 4 0.0000
452 BLOOD PRESSURE FLUCTUATION 1 0.0000
453 DIABETIC KETOACIDOSIS 1 0.0000
454 MYALGIA 7 0.0000
455 PRESYNCOPE 1 0.0000
456 LUNG DISORDER 2 0.0000
457 LIVER INJURY 1 0.0000
458 ENCEPHALOPATHY 1 0.0000
459 BRONCHITIS 3 0.0000
460 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
461 HOT FLUSH 3 0.0000
462 HEPATITIS 1 0.0000
463 THERAPY CESSATION 2 0.0000
464 ANAPHYLACTIC SHOCK 1 0.0000
465 UNRESPONSIVE TO STIMULI 1 0.0000
466 JOINT STIFFNESS 1 0.0000
467 GASTRITIS 1 0.0000
468 PANCREATITIS 2 0.0000
469 INSOMNIA 10 0.0000
470 DEHYDRATION 5 0.0000
471 GASTROOESOPHAGEAL REFLUX DISEASE 3 0.0000
472 JAUNDICE 1 0.0000
473 FREQUENT BOWEL MOVEMENTS 1 0.0000
474 BLOOD BILIRUBIN INCREASED 1 0.0000
475 RASH PRURITIC 2 0.0000
476 LIMB INJURY 1 0.0000
477 PNEUMONITIS 1 0.0000
478 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0000
479 PRODUCT USE IN UNAPPROVED INDICATION 9 0.0000
480 HAEMATOCHEZIA 2 0.0000
481 DIZZINESS 18 0.0000
482 PROCEDURAL PAIN 1 0.0000
483 COUGH 10 0.0000
484 ASTHMA 4 0.0000
485 INCORRECT DOSE ADMINISTERED 8 0.0000
486 ANGINA PECTORIS 1 0.0000
487 HYPERSOMNIA 1 0.0000
488 LIVER FUNCTION TEST ABNORMAL 1 0.0000
489 NEEDLE ISSUE 1 0.0000
490 MALAISE 15 0.0000
491 PALPITATIONS 4 0.0000
492 URINARY INCONTINENCE 1 0.0000
493 HEPATIC FAILURE 1 0.0000
494 APHASIA 1 0.0000
495 LACRIMATION INCREASED 1 0.0000
496 FALL 11 0.0000
497 HYPOTHYROIDISM 1 0.0000
498 METABOLIC ACIDOSIS 1 0.0000
499 LOSS OF CONSCIOUSNESS 4 0.0000
500 CONTUSION 3 0.0000
501 DYSPEPSIA 3 0.0000
502 STAPHYLOCOCCAL INFECTION 1 0.0000
503 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
504 BACK PAIN 7 0.0000
505 VIRAL INFECTION 1 0.0000
506 FUNGAL INFECTION 1 0.0000
507 GAIT INABILITY 1 0.0000
508 HYPOTENSION 6 0.0000
509 EYE PRURITUS 1 0.0000
510 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
511 CHEST DISCOMFORT 3 0.0000
512 SINUSITIS 3 0.0000
513 ERYTHEMA 6 0.0000
514 PYREXIA 10 0.0000
515 DELIRIUM 1 0.0000
516 HEART RATE DECREASED 1 0.0000
517 LYMPHADENOPATHY 1 0.0000
518 CEREBRAL HAEMORRHAGE 1 0.0000
519 OVERDOSE 6 0.0000
520 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
521 EYE SWELLING 1 0.0000
522 EPISTAXIS 2 0.0000
523 DYSARTHRIA 1 0.0000
524 COLITIS 1 0.0000
525 ANAEMIA 5 0.0000
526 PAIN 16 0.0000
527 ALOPECIA 5 0.0000
528 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
529 WEIGHT DECREASED 7 0.0000
530 ABORTION SPONTANEOUS 1 0.0000
531 DRY MOUTH 2 0.0000
532 BLINDNESS 1 0.0000
533 INFLUENZA LIKE ILLNESS 2 0.0000
534 ARTHRALGIA 10 0.0000
535 POLLAKIURIA 1 0.0000
536 CARDIO-RESPIRATORY ARREST 1 0.0000
537 ROAD TRAFFIC ACCIDENT 1 0.0000
538 HYPOACUSIS 1 0.0000
539 BALANCE DISORDER 2 0.0000
540 VAGINAL HAEMORRHAGE 1 0.0000
541 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
542 COVID-19 4 0.0000
543 PULMONARY OEDEMA 1 0.0000
544 ADVERSE DRUG REACTION 2 0.0000
545 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
546 OROPHARYNGEAL PAIN 2 0.0000
547 CHEST PAIN 4 0.0000
548 PRODUCT USE ISSUE 4 0.0000
549 ARRHYTHMIA 1 0.0000
550 ANXIETY 6 0.0000
551 COMA 1 0.0000
552 RASH ERYTHEMATOUS 1 0.0000
553 FEELING ABNORMAL 5 0.0000
554 BLOOD GLUCOSE DECREASED 1 0.0000
555 ATRIAL FIBRILLATION 2 0.0000
556 HEART RATE INCREASED 2 0.0000
557 HYPOAESTHESIA 3 0.0000
558 CELLULITIS 1 0.0000
559 DYSPNOEA 11 0.0000
560 INFLAMMATION 1 0.0000
561 ABDOMINAL DISTENSION 2 0.0000
562 SPEECH DISORDER 1 0.0000
563 BRADYCARDIA 1 0.0000
564 ANAPHYLACTIC REACTION 1 0.0000
565 TREMOR 3 0.0000
566 ARTHROPATHY 1 0.0000
567 MEDICATION ERROR 1 0.0000
568 SEPSIS 2 0.0000
569 URTICARIA 3 0.0000
570 OXYGEN SATURATION DECREASED 1 0.0000
571 URINARY TRACT INFECTION 3 0.0000
572 BONE PAIN 1 0.0000
573 NASAL CONGESTION 1 0.0000
574 PAIN IN EXTREMITY 5 0.0000
575 DISEASE PROGRESSION 2 0.0000
576 EMOTIONAL DISTRESS 2 0.0000
577 SUICIDE ATTEMPT 1 0.0000
578 PLEURAL EFFUSION 1 0.0000
579 VISUAL IMPAIRMENT 2 0.0000
580 PRURITUS 6 0.0000
581 HYPERHIDROSIS 2 0.0000
582 PNEUMONIA 5 0.0000
583 SWELLING FACE 1 0.0000
584 DRUG INEFFECTIVE 20 0.0000
585 BLOOD PRESSURE DECREASED 1 0.0000
586 DRY SKIN 2 0.0000
587 HEPATIC ENZYME INCREASED 1 0.0000
588 MEMORY IMPAIRMENT 2 0.0000
589 DEVICE MALFUNCTION 1 0.0000
590 INJURY 1 0.0000
591 SKIN BURNING SENSATION 1 0.0000
592 INFECTION 2 0.0000
593 RASH 6 0.0000
594 UNDERDOSE 1 0.0000
595 DYSGEUSIA 1 0.0000
596 DIABETES MELLITUS 1 0.0000
597 BLOOD PRESSURE INCREASED 2 0.0000
598 ARTHRITIS 1 0.0000
599 DRUG INTERACTION 2 0.0000
600 CARDIAC FAILURE 1 0.0000
601 CONFUSIONAL STATE 2 0.0000
602 CARDIAC ARREST 1 0.0000
603 PRODUCT STORAGE ERROR 1 0.0000
604 INTENTIONAL PRODUCT MISUSE 1 0.0000
605 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
606 ADVERSE EVENT 1 0.0000
607 CARDIAC DISORDER 1 0.0000
608 PULMONARY EMBOLISM 1 0.0000
609 NEUROPATHY PERIPHERAL 1 0.0000
610 MIGRAINE 1 0.0000
611 GAIT DISTURBANCE 2 0.0000
612 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
613 MUSCULAR WEAKNESS 1 0.0000
614 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
615 OEDEMA PERIPHERAL 1 0.0000
616 PSORIASIS 1 0.0000
617 RENAL FAILURE 1 0.0000
618 VISION BLURRED 1 0.0000
619 CONDITION AGGRAVATED 2 0.0000
620 ACUTE KIDNEY INJURY 1 0.0000
621 PERIPHERAL SWELLING 1 0.0000
622 PARAESTHESIA 1 0.0000
623 CEREBROVASCULAR ACCIDENT 1 0.0000
624 NO ADVERSE EVENT 1 0.0000
625 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
626 HYPERTENSION 1 0.0000
627 DEATH 3 0.0000